Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP - News) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, Cholera and malaria detection, and other innovative technologies, today announced the Company will meet with scientific and research leaders at the Global Tuberculosis Surveillance Workshop, sponsored by Los Alamos National Laboratory. The conference will bring together experts from around the world with the intent of building a research community dedicated to developing techniques and strategies for the surveillance and management of drug-resistant tuberculosis. The Workshop is being held this week in Santa Fe, New Mexico.

Clayton Hardman, CEO of Biomagnetics Diagnostics Corp. advised, “This is an extremely important event in establishing relationships on a global basis. Many tuberculosis detection technologies lack accuracy and are still too expensive to be deployed in many parts of the world where tuberculosis is endemic. Importantly, the main objective of these meetings is to develop and demonstrate the underlying capabilities for high throughput screening and analysis, and we believe Biomagnetics is particularly well equipped to contribute toward these goals.”

Mr. Hardman continued, “As we move closer to the completion of our collaborative research agreement with our research partners, the integrated optical biosensor technology is gaining increased exposure and receiving increased attention. We are confident that the integrated optical biosensor product we plan to introduce to the market holds strong potential to revolutionize tuberculosis diagnostics worldwide.” Mr. Hardman concluded, “We plan on meeting with as many of the participants as time permits".

About Biomagnetics Diagnostics Corp.

Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company and an acquirer of other innovative technologies. The Company is currently developing a waveguide-based advanced integrated optical biosensor through its cooperative research and development agreement with Los Alamos National Security, LLC, which will initially be used for cholera, tuberculosis and malaria diagnosis. More information on Biomagnetics Diagnostics Corp. can be seen at www.biomagneticsbmgp.com.

Biomagnetics Diagnostics (CE) (USOTC:BMGP)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos Biomagnetics Diagnostics (CE).
Biomagnetics Diagnostics (CE) (USOTC:BMGP)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos Biomagnetics Diagnostics (CE).